Improvement of dry mouth by replacing paroxetine with fluvoxamine

Yuka Arima, Chiharu Kubo, Masayuki Tsujimoto, Hisakazu Ohtani, Yasufumi Sawada

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

OBJECTIVE: To present a case of improvement of paroxetine-induced dry mouth by substitution of fluvoxamine and analyze this case based on receptor occupancy theory. CASE SUMMARY: A 66-year-old woman with major depressive disorder had been treated with brotizolam 0.5 mg/day, flunitrazepam 2 mg/day, sulpiride 100 mg/day, bromazepam 2 mg/day, trazodone 25 mg/day, and paroxetine hydrochloride 10 mg/day. Although her psychological symptoms improved gradually, she complained of dry mouth. Paroxetine was replaced with fluvoxamine maleate 50 mg/day, and the dryness disappeared within a month. DISCUSSION: We calculated the time courses of muscarinic acetylcholine (mACh) receptor occupancy after oral administration of paroxetine and fluvoxamine at the treatment doses by using pharmacokinetic parameters obtained from the literature. The mACh receptor occupancy was estimated to be decreased from 0.22% to 0.020% by replacing paroxetine with fluvoxamine. CONCLUSIONS: The improvement of dry mouth observed after the replacement of paroxetine with fluvoxamine in this patient may have been due to a decrease in the mACh receptor occupancy.

Original languageEnglish
Pages (from-to)567-571
Number of pages5
JournalAnnals of Pharmacotherapy
Volume39
Issue number3
DOIs
Publication statusPublished - 2005 Mar
Externally publishedYes

Fingerprint

Fluvoxamine
Paroxetine
Mouth
Muscarinic Receptors
brotizolam
Bromazepam
Trazodone
Flunitrazepam
Sulpiride
Major Depressive Disorder
Oral Administration
Pharmacokinetics
Psychology

Keywords

  • Dry mouth
  • Fluvoxamine
  • Paroxetine

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Improvement of dry mouth by replacing paroxetine with fluvoxamine. / Arima, Yuka; Kubo, Chiharu; Tsujimoto, Masayuki; Ohtani, Hisakazu; Sawada, Yasufumi.

In: Annals of Pharmacotherapy, Vol. 39, No. 3, 03.2005, p. 567-571.

Research output: Contribution to journalArticle

Arima, Yuka ; Kubo, Chiharu ; Tsujimoto, Masayuki ; Ohtani, Hisakazu ; Sawada, Yasufumi. / Improvement of dry mouth by replacing paroxetine with fluvoxamine. In: Annals of Pharmacotherapy. 2005 ; Vol. 39, No. 3. pp. 567-571.
@article{5a3ba77bdc224af4a237fe849518f409,
title = "Improvement of dry mouth by replacing paroxetine with fluvoxamine",
abstract = "OBJECTIVE: To present a case of improvement of paroxetine-induced dry mouth by substitution of fluvoxamine and analyze this case based on receptor occupancy theory. CASE SUMMARY: A 66-year-old woman with major depressive disorder had been treated with brotizolam 0.5 mg/day, flunitrazepam 2 mg/day, sulpiride 100 mg/day, bromazepam 2 mg/day, trazodone 25 mg/day, and paroxetine hydrochloride 10 mg/day. Although her psychological symptoms improved gradually, she complained of dry mouth. Paroxetine was replaced with fluvoxamine maleate 50 mg/day, and the dryness disappeared within a month. DISCUSSION: We calculated the time courses of muscarinic acetylcholine (mACh) receptor occupancy after oral administration of paroxetine and fluvoxamine at the treatment doses by using pharmacokinetic parameters obtained from the literature. The mACh receptor occupancy was estimated to be decreased from 0.22{\%} to 0.020{\%} by replacing paroxetine with fluvoxamine. CONCLUSIONS: The improvement of dry mouth observed after the replacement of paroxetine with fluvoxamine in this patient may have been due to a decrease in the mACh receptor occupancy.",
keywords = "Dry mouth, Fluvoxamine, Paroxetine",
author = "Yuka Arima and Chiharu Kubo and Masayuki Tsujimoto and Hisakazu Ohtani and Yasufumi Sawada",
year = "2005",
month = "3",
doi = "10.1345/aph.1E486",
language = "English",
volume = "39",
pages = "567--571",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "3",

}

TY - JOUR

T1 - Improvement of dry mouth by replacing paroxetine with fluvoxamine

AU - Arima, Yuka

AU - Kubo, Chiharu

AU - Tsujimoto, Masayuki

AU - Ohtani, Hisakazu

AU - Sawada, Yasufumi

PY - 2005/3

Y1 - 2005/3

N2 - OBJECTIVE: To present a case of improvement of paroxetine-induced dry mouth by substitution of fluvoxamine and analyze this case based on receptor occupancy theory. CASE SUMMARY: A 66-year-old woman with major depressive disorder had been treated with brotizolam 0.5 mg/day, flunitrazepam 2 mg/day, sulpiride 100 mg/day, bromazepam 2 mg/day, trazodone 25 mg/day, and paroxetine hydrochloride 10 mg/day. Although her psychological symptoms improved gradually, she complained of dry mouth. Paroxetine was replaced with fluvoxamine maleate 50 mg/day, and the dryness disappeared within a month. DISCUSSION: We calculated the time courses of muscarinic acetylcholine (mACh) receptor occupancy after oral administration of paroxetine and fluvoxamine at the treatment doses by using pharmacokinetic parameters obtained from the literature. The mACh receptor occupancy was estimated to be decreased from 0.22% to 0.020% by replacing paroxetine with fluvoxamine. CONCLUSIONS: The improvement of dry mouth observed after the replacement of paroxetine with fluvoxamine in this patient may have been due to a decrease in the mACh receptor occupancy.

AB - OBJECTIVE: To present a case of improvement of paroxetine-induced dry mouth by substitution of fluvoxamine and analyze this case based on receptor occupancy theory. CASE SUMMARY: A 66-year-old woman with major depressive disorder had been treated with brotizolam 0.5 mg/day, flunitrazepam 2 mg/day, sulpiride 100 mg/day, bromazepam 2 mg/day, trazodone 25 mg/day, and paroxetine hydrochloride 10 mg/day. Although her psychological symptoms improved gradually, she complained of dry mouth. Paroxetine was replaced with fluvoxamine maleate 50 mg/day, and the dryness disappeared within a month. DISCUSSION: We calculated the time courses of muscarinic acetylcholine (mACh) receptor occupancy after oral administration of paroxetine and fluvoxamine at the treatment doses by using pharmacokinetic parameters obtained from the literature. The mACh receptor occupancy was estimated to be decreased from 0.22% to 0.020% by replacing paroxetine with fluvoxamine. CONCLUSIONS: The improvement of dry mouth observed after the replacement of paroxetine with fluvoxamine in this patient may have been due to a decrease in the mACh receptor occupancy.

KW - Dry mouth

KW - Fluvoxamine

KW - Paroxetine

UR - http://www.scopus.com/inward/record.url?scp=13944267044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13944267044&partnerID=8YFLogxK

U2 - 10.1345/aph.1E486

DO - 10.1345/aph.1E486

M3 - Article

C2 - 15701774

AN - SCOPUS:13944267044

VL - 39

SP - 567

EP - 571

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 3

ER -